» Articles » PMID: 30464343

Efferocytosis Induces a Novel SLC Program to Promote Glucose Uptake and Lactate Release

Overview
Journal Nature
Specialty Science
Date 2018 Nov 23
PMID 30464343
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

Development and routine tissue homeostasis require a high turnover of apoptotic cells. These cells are removed by professional and non-professional phagocytes via efferocytosis. How a phagocyte maintains its homeostasis while coordinating corpse uptake, processing ingested materials and secreting anti-inflammatory mediators is incompletely understood. Here, using RNA sequencing to characterize the transcriptional program of phagocytes actively engulfing apoptotic cells, we identify a genetic signature involving 33 members of the solute carrier (SLC) family of membrane transport proteins, in which expression is specifically modulated during efferocytosis, but not during antibody-mediated phagocytosis. We assessed the functional relevance of these SLCs in efferocytic phagocytes and observed a robust induction of an aerobic glycolysis program, initiated by SLC2A1-mediated glucose uptake, with concurrent suppression of the oxidative phosphorylation program. The different steps of phagocytosis-that is, 'smell' ('find-me' signals or sensing factors released by apoptotic cells), 'taste' (phagocyte-apoptotic cell contact) and 'ingestion' (corpse internalization)-activated distinct and overlapping sets of genes, including several SLC genes, to promote glycolysis. SLC16A1 was upregulated after corpse uptake, increasing the release of lactate, a natural by-product of aerobic glycolysis. Whereas glycolysis within phagocytes contributed to actin polymerization and the continued uptake of corpses, lactate released via SLC16A1 promoted the establishment of an anti-inflammatory tissue environment. Collectively, these data reveal a SLC program that is activated during efferocytosis, identify a previously unknown reliance on aerobic glycolysis during apoptotic cell uptake and show that glycolytic by-products of efferocytosis can influence surrounding cells.

Citing Articles

Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer.

Pulica R, Aquib A, Varsanyi C, Gadiyar V, Wang Z, Frederick T Cell Commun Signal. 2025; 23(1):131.

PMID: 40069722 PMC: 11900106. DOI: 10.1186/s12964-025-02090-6.


Impact of zinc on immunometabolism and its putative role on respiratory diseases.

Yao J, Ortega E, Panda A Immunometabolism (Cobham). 2025; 7(1):e00057.

PMID: 40051614 PMC: 11882175. DOI: 10.1097/IN9.0000000000000057.


The role of efferocytosis in inflammatory bowel disease.

Liu Y, Li Z, Han Y, Wang Q Front Immunol. 2025; 16:1524058.

PMID: 40040696 PMC: 11876057. DOI: 10.3389/fimmu.2025.1524058.


Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells.

Lv J, Jiao Y, Zhao X, Kong X, Chen Y, Li L CNS Neurosci Ther. 2025; 31(2):e70229.

PMID: 39945118 PMC: 11822359. DOI: 10.1111/cns.70229.


Role of RPE Phagocytosis in the Retina Metabolic Ecosystem.

Etchegaray J, Ravichandran K Adv Exp Med Biol. 2025; 1468:429-433.

PMID: 39930233 DOI: 10.1007/978-3-031-76550-6_70.


References
1.
Elliott M, Ravichandran K . The Dynamics of Apoptotic Cell Clearance. Dev Cell. 2016; 38(2):147-60. PMC: 4966906. DOI: 10.1016/j.devcel.2016.06.029. View

2.
Verdone J, Zarif J, Pienta K . Aerobic glycolysis, motility, and cytoskeletal remodeling. Cell Cycle. 2014; 14(2):169-70. PMC: 4353074. DOI: 10.1080/15384101.2014.995493. View

3.
Cesar-Razquin A, Snijder B, Frappier-Brinton T, Isserlin R, Gyimesi G, Bai X . A Call for Systematic Research on Solute Carriers. Cell. 2015; 162(3):478-87. DOI: 10.1016/j.cell.2015.07.022. View

4.
Takanaga H, Chaudhuri B, Frommer W . GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta. 2008; 1778(4):1091-9. PMC: 2315637. DOI: 10.1016/j.bbamem.2007.11.015. View

5.
Palmada M, Boehmer C, Akel A, Rajamanickam J, Jeyaraj S, Keller K . SGK1 kinase upregulates GLUT1 activity and plasma membrane expression. Diabetes. 2006; 55(2):421-7. DOI: 10.2337/diabetes.55.02.06.db05-0720. View